Cadila Pharms Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CADILA PHARMS LTD, and what generic and branded alternatives to CADILA PHARMS LTD drugs are available?
CADILA PHARMS LTD has thirty approved drugs.
Drugs and US Patents for Cadila Pharms Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cadila Pharms Ltd | CELECOXIB | celecoxib | CAPSULE;ORAL | 208701-004 | Nov 14, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cadila Pharms Ltd | ERYTHROMYCIN ETHYLSUCCINATE | erythromycin ethylsuccinate | GRANULE;ORAL | 216212-001 | Nov 21, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cadila Pharms Ltd | NEBIVOLOL HYDROCHLORIDE | nebivolol hydrochloride | TABLET;ORAL | 208717-004 | Dec 17, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cadila Pharms Ltd | NEBIVOLOL HYDROCHLORIDE | nebivolol hydrochloride | TABLET;ORAL | 208717-002 | Dec 17, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cadila Pharms Ltd | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 212103-002 | Oct 16, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Cadila Pharms Ltd | PREGABALIN | pregabalin | CAPSULE;ORAL | 206452-003 | Jul 12, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.